Creatine kinase IVDs
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
27-05-2019
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Abbott Australasia Pty Ltd Diagnostic Division
Class:
Class 3
Manufactured by:
Sentinel CH SpA Via Robert Koch 2, Milan, 20152 Italy
Therapeutic area:
CT831 - Creatine kinase IVDs
Therapeutic indications:
The Alinity c CK-MB assay is used for the kinetic determination of the CK-MB and CK-BB isoenzymes of creatine kinase in serum or plasma on the Alinity c analyzer
Authorization status:
A
Authorization date:
2018-05-29
